Essential Oil Enriched with Oxygenated Constituents from Invasive Plant Argemone ochroleuca Exhibited Potent Phytotoxic Effects

Essential Oil Enriched with Oxygenated Constituents from Invasive Plant Argemone ochroleuca Exhibited Potent Phytotoxic Effects

Invasive species are thought of as one of many main threats to ecosystems worldwide. Although invasive vegetation are thought to be a foe, they might be thought of as pure assets for invaluable bioactive compounds. The current examine aimed to characterize the chemical composition of the important oil (EO) from the invasive plant Argemone ochroleuca Sweet, collected from Saudi Arabia, in addition to to judge its phytotoxic exercise. Seventy-four compounds have been characterised by way of GC-MS evaluation of EO representing 98.75% of the general mass.

The oxygenated constituents (79.01%) have been discovered as the primary constituents, together with mono- (43.27%), sesqui- (17.67%), and di-terpenes (0.53%), in addition to hydrocarbons (16.81%) and carotenoids (0.73%). Additionally, 19.69% from the general mass was characterised as non-oxygenated compounds with mono- (1.77%), sesquiterpenes (17.41%), and hydrocarbons (0.56%) as minors. From all recognized constituents, trans-chrysanthenyl acetate (25.71%), γ-cadinene (11.70%), oleic acid, methyl ester (7.37%), terpinene-4-ol (4.77%), dihydromyrcenol (2.90%), α-muurolene (1.77%), and γ-himachalene (1.56%) have been discovered as considerable.

The EO of A. ochroleuca confirmed vital phytotoxic exercise towards the take a look at plant Lactuca sativa and the noxious weed Peganum harmala. The EO attained IC50 values of 92.1, 128.6, and 131.6 µL L-1 for seedling root development, germination, and shoot development of L. sativa, respectively, whereas it had IC50 values of 134.8, 145.7, and 147.9 µL L-1, respectively, for P. harmala. Therefore, this EO might be used as a bioherbicide towards weeds, whereas additional examine is advisable for the characterization of the genuine supplies of the primary compounds within the EO in addition to for the analysis of efficiency of this oil on a subject scale and the dedication of its biosafety.

 Essential Oil Enriched with Oxygenated Constituents from Invasive Plant Argemone ochroleuca Exhibited Potent Phytotoxic Effects
Essential Oil Enriched with Oxygenated Constituents from Invasive Plant Argemone ochroleuca Exhibited Potent Phytotoxic Effects

The function of breast FNA throughout and post- COVID-19 pandemic: a quick and secure various to needle core biopsy

The coronavirus illness 2019 (COVID-19) has been very taxing to healthcare techniques worldwide. As assets are diverted to deal with COVID-19, capability for diagnostic and therapeutic procedures of different illnesses is decreased, leading to delays and ready lists. This is especially necessary within the context of oncology, specifically breast most cancers.

All sufferers with suspicious breast lesions want pathological affirmation of malignancy so as to be handled; sadly, many of those procedures have been delayed. Nowadays these lesions are often identified utilizing core needle biopsies (CNB). When in comparison with fine-needle aspiration biopsies (FNAB), they’re perceived to be extra exact and supply higher materials for biomarker testing. However, FNABs are faster to carry out, more cost effective and minimally invasive, which would appear advantageous within the context of rising ready lists.

We would invite the reader to problem their preconceptions of breast FNABs: not solely have ancillary assessments have been proven to be viable on each smears and cell blocks however, in 2019, the Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology was developed and validated, enabling an correct and reproducible categorization of breast lesions, considerably decreasing the necessity for follow-up CNBs. Thus, the most important limitations of breast FNABs have been addressed. Furthermore, they’re much less invasive, resulting in a decrease danger of an infection for personnel when customary biosafety procedures are adopted.

VEGFR binding peptide IVLS / RKRKRKKSRYIVLS

007-59 100 μg
EUR 171.72

Peptide Lv (Human)

008-71 100 μg
EUR 405

Peptide YY (PYY) (Human) - Antibody

H-059-01 100 μl
EUR 469.8

Peptide YY (PYY) (Human)

059-01 200 μg
EUR 119.88

Anti-Inflammatory Peptide 1

004-01 200 μg
EUR 27

Anti-Inflammatory Peptide 2

004-02 200 μg
EUR 27

Anti-Inflammatory Peptide 3

004-03 200 μg
EUR 27

Peptide YY (PYY) (3-36) (Human) - Antibody

H-059-02 100 μl
EUR 604.8

VEGF (125-136) (Human)

007-57 100 μg
EUR 158.76

Anti-Angiogenic Peptide Library

L-008A 88 peptides
EUR 6067.44

GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human)

029-03 500 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human)

029-04 100 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human)

029-05 20 μg
EUR 267.84

GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human)

029-06 100 μg
EUR 114.48

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody

H-064-07 50 μl
EUR 238.68

Peptide YY (PYY) (3-36)-Gly (Human) - Antibody

H-059-08 100 μl
EUR 469.8

Galanin-Like Peptide (GALP) (Human) - Antibody

H-026-51 50 μl
EUR 604.8

[Cys0]-Peptide YY (PYY) (3-19) (Human) - Antibody

H-059-16 100 μl
EUR 469.8

[Cys20]-Peptide YY (PYY) (3-19) (Human) - Antibody

H-059-17 100 μl
EUR 469.8

Peptide-Depleted Plasma (Human)

MB-099-01 2 ml
EUR 119.88

Peptide YY (PYY) (3-36) (Human)

059-02 200 μg
EUR 102.6

Peptide YY (PYY) (Human) - Purified IgG Antibody

G-059-01 400 μg
EUR 438.48

Gastrin Releasing Peptide (GRP) (Human) - Antibody

H-027-07 50 μl
EUR 238.68

Stresscopin Related Peptide (SRP) (Human) - Antibody

H-019-27 50 μl
EUR 604.8

C28 optimized peptide 6 (Human)

073-82 100 μg
EUR 235.44

Peptide YY (PYY) (Human) - EIA Kit

EK-059-01 96 wells
EUR 617.76

Peptide YY (PYY) (Human) - RIA Kit

RK-059-01 125 tubes
EUR 814.32

Galanin-Like Peptide (GALP) (Human)

026-51 100 μg
EUR 230.04

PACAP-Related Peptide (PRP) (Human)

052-10 200 μg
EUR 86.4

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human)

064-07 200 μg
EUR 114.48

T3 Peptide / Tumstatin (69-88) (Human)

016-50 100 μg
EUR 255.96

T7 Peptide / Tumstatin (74-98) (Human)

016-51 100 μg
EUR 255.96

Galanin-Like Peptide (GALP) (36-60) (Human) - Antibody

H-026-55 50 μl
EUR 604.8

Peptide YY (PYY) (1-36)-Gly (Human)

059-07 100 μg
EUR 295.92

Peptide YY (PYY) (3-36)-Gly (Human)

059-08 100 μg
EUR 282.96

Peptide YY (PYY) (2-36)-Gly (Human)

059-11 100 μg
EUR 267.84

Peptide YY (PYY) (4-36)-Gly (Human)

059-12 100 μg
EUR 267.84

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Purified IgG Antibody

G-064-07 400 μg
EUR 438.48

Gastrin Releasing Peptide (GRP) (Human)

027-07 200 μg
EUR 119.88

Peptide YY (PYY) (3-36) (Human) - Purified IgG Antibody

G-059-02 200 μg
EUR 604.8

Prolactin-Releasing Peptide-31 (PrRP-31) (Human) - Antibody

H-008-50 50 μl
EUR 604.8

SHAAG Peptide / Chemokine (46-63) (Human)

072-32 100 μg
EUR 160.92

Stresscopin Related Peptide (SRP) (Human)

019-27 100 μg
EUR 214.92

Fractalkine Chemokine Domain peptide (41-52) (Human)

026-82 200 μg
EUR 160.92

Fractalkine Chemokine Domain peptide (53-60) (Human)

026-83 200 μg
EUR 135

Fractalkine Chemokine Domain peptide (60-71) (Human)

026-84 200 μg
EUR 160.92

C28 optimized peptide 15 Dimer (Human)

073-86 100 μg
EUR 420.12

RFamide-Related Peptide 3 (RFRP-3) (Human) - Antibody

H-048-46 100 μl
EUR 604.8

Peptide YY (PYY) (3-36) (Human) - EIA Kit

EK-059-02 96 wells
EUR 617.76

Peptide YY (PYY) (3-36) (Human) - RIA Kit

RK-059-02 125 tubes
EUR 814.32

Osteoblast Activating Peptide (OBAP) (Human)

055-52 100 μg
EUR 199.8

Human Proteome Signature Peptide Library

L-010 98 peptides
EUR 7804.08

Nesfatin-1-Like Peptide (NLP) (Human)

009-83 100 μg
EUR 469.8

APP 17mer peptide / APP770 (204-220) (Human)

018-74 100 μg
EUR 135

Urotensin II Related Peptide (Human, Rat, Mouse) - Antibody

H-071-17 50 μl
EUR 604.8

C28 optimized peptide 15 Monomer (Human)

073-84 100 μg
EUR 258.12

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit

RK-064-07 125 tubes
EUR 932.04

Peptide YY (PYY) (Human) - I-125 Labeled

T-059-01 10 μCi
EUR 1145.88

Defensin I / Human Neutrophil Peptide-1 (HNP-1) (Human)

072-17 100 μg
EUR 370.44

Galanin-Like Peptide (GALP) (Human) - Purified IgG Antibody

G-026-51 200 μg
EUR 604.8

SHLP1 / Small Humanin-Like Peptide 1 (Human)

018-75 100 μg
EUR 263.52

SHLP2 / Small Humanin-Like Peptide 2 (Human)

018-76 100 μg
EUR 263.52

SHLP3 / Small Humanin-Like Peptide 3 (Human)

018-77 100 μg
EUR 422.28

SHLP4 / Small Humanin-Like Peptide 4 (Human)

018-78 100 μg
EUR 289.44

SHLP5 / Small Humanin-Like Peptide 5 (Human)

018-79 100 μg
EUR 316.44

SHLP6 / Small Humanin-Like Peptide 6 (Human)

018-80 100 μg
EUR 250.56

Galanin-Like Peptide (GALP) (36-60) (Human)

026-55 200 μg
EUR 177.12

FGF23 (188-199 )optimized peptide 10 (Human)

073-88 100 μg
EUR 258.12

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - FAM Labeled

FG-064-07A 1 nmol
EUR 336.96

Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401

004-04 100 μg
EUR 140.4

Peptide YY (PYY) (3-36) (Human) - FAM Labeled

FG-059-02A 1 nmol
EUR 336.96

Prolactin-Releasing Peptide-31 (PrRP-31) (Human)

008-50 200 μg
EUR 199.8

Prolactin-Releasing Peptide-20 (PrRP-20) (Human)

008-51 200 μg
EUR 199.8

Gastrin Releasing Peptide (GRP) (Human) - Purified IgG Antibody

G-027-07 400 μg
EUR 438.48

Agouti-Related Peptide (AgRP) (83-132) amide (Human) - Antibody

H-003-53 50 μl
EUR 469.8

Gastrin Releasing Peptide (GRP) (18-27) (Human)

027-41 200 μg
EUR 160.92

Agouti-Related Peptide (AgRP) (25-51) (Human)

003-51 200 μg
EUR 129.6

Agouti-Related Peptide (AgRP) (54-82) (Human)

003-52 200 μg
EUR 129.6

Agouti-Related Peptide (AgRP) (25-82) (Human)

003-74 100 μg
EUR 497.88

Gastrin Releasing Peptide (GRP) (1-16) (Human)

027-08 1 mg
EUR 177.12

Gastrin Releasing Peptide (GRP) (1-17) (Human)

027-42 200 μg
EUR 189

Seminal Plasma Inhibin-Like Peptide (Human)

034-03 200 μg
EUR 194.4

Galanin-Like Peptide (GALP) (Human) - RIA Kit

RK-026-51 125 tubes
EUR 932.04

Stresscopin Related Peptide (SRP) (Human) - Purified IgG Antibody

G-019-27 200 μg
EUR 604.8

Peptide YY (PYY) (3-36) (Human) - Biotin Labeled

B-059-02 10 μg
EUR 405

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - I-125 Labeled

T-064-07 10 μCi
EUR 1145.88

RFamide-Related Peptide 1 (RFRP-1) (Human)

048-42 500 μg
EUR 177.12

RFamide-Related Peptide 2 (RFRP-2) (Human)

048-44 500 μg
EUR 177.12

RFamide-Related Peptide 3 (RFRP-3) (Human)

048-46 500 μg
EUR 177.12

Gastrin Releasing Peptide (GRP) (Human) - EIA Kit

EK-027-07 96 wells
EUR 603.72

Gastrin Releasing Peptide (GRP) (Human) - RIA Kit

RK-027-07 125 tubes
EUR 932.04

Prolactin-Releasing Peptide-31 (PrRP-31) (Human) - Purified IgG Antibody

G-008-50 400 μg
EUR 604.8

Urotensin II Related Peptide (Human, Rat, Mouse)

071-17 200 μg
EUR 129.6

Peptide YY (PYY) (3-36) (Human) - I-125 Labeled

T-059-02 10 μCi
EUR 1145.88

Galanin-Like Peptide (GALP) (36-60) (Human) - Purified IgG Antibody

G-026-55 200 μg
EUR 604.8

[Tyr0]-pro-Gastrin Releasing Peptide (GRP) (80-97) (Human) - Antibody

H-027-36 100 μl
EUR 370.44

T3 Peptide / Tumstatin (69-88) (Human) - FAM Labeled

FG-016-50A 1 nmol
EUR 469.8

T7 Peptide / Tumstatin (74-98) (Human) - FAM Labeled

FG-016-51A 1 nmol
EUR 469.8

Peptide YY (PYY) (3-36) (Human) - Rhodamine Labeled

FR-059-02 1 nmol
EUR 405

Galanin-Like Peptide (GALP) (Human) - FAM Labeled

FG-026-51A 1 nmol
EUR 604.8

Stresscopin Related Peptide (SRP) (Human) - RIA Kit

RK-019-27 125 tubes
EUR 1341.36

[Tyr0]-Agouti-Related Peptide (AgRP) (25-51) (Human)

003-72 100 μg
EUR 416.88

[Tyr0]-Agouti-Related Peptide (AgRP) (54-82) (Human)

003-73 100 μg
EUR 416.88

R3 (BDelta23-27) R / I5 Chimeric Peptide (Human)

035-66 100 μg
EUR 604.8

Nesfatin-1-Like Peptide(NLP) (Human) - RIA Kit

RK-009-83 125 tubes
EUR 980.64

Gastrin Releasing Peptide-Gly (GRP-Gly) (Human)

027-37 100 μg
EUR 160.92

[Leu(13C)6,(15N)-15,22]-Peptide YY (PYY) (3-36) (Human)

SIL-059-02 20 μg
EUR 1186.92

pro-Gastrin Releasing Peptide (GRP) (42-98) (Human)

027-34 100 μg
EUR 355.32

pro-Gastrin Releasing Peptide (GRP) (47-68) (Human)

027-35 100 μg
EUR 160.92

SHAAG Peptide / Chemokine (46-63) (Human) - Cy3 Labeled

FC3-072-32 1 nmol
EUR 587.52

SHAAG Peptide / Chemokine (46-63) (Human) - Cy5 Labeled

FC5-072-32 1 nmol
EUR 587.52

SHAAG Peptide / Chemokine (46-63) (Human) - FAM Labeled

FG-072-32A 1 nmol
EUR 267.84

Osteoblast Activating Peptide (OBAP) (Human) - EIA Kit

EK-055-52 96 wells
EUR 660.96

Osteoblast Activating Peptide (OBAP) (Human) - RIA Kit

RK-055-52 125 tubes
EUR 980.64

7B2 Carboxyl-terminal (CT) peptide (Human, Porcine)

004-32 100 μg
EUR 160.92

Peptide YY (PYY) (3-36) (Human) - MagBead (Magnetic Bead Linked Antibody)

MB-059-02 1 ml
EUR 842.4

Peptide YY (PYY) (3-36) (Human) - Fluorescent EIA Kit

FEK-059-02 96 wells
EUR 660.96

prepro-Galanin-Like Peptide (GALP) (87-116) (Human)

026-54 200 μg
EUR 230.04

prepro-RFamide Related Peptide (RFRP) (56-92) amide (Human) - Antibody

H-048-54 100 μl
EUR 604.8

prepro-RFamide Related Peptide (RFRP) (115-131) amide (Human) - Antibody

H-048-55 50 μl
EUR 604.8

Stresscopin Related Peptide (SRP) (Human) - FAM Labeled

FG-019-27A 1 nmol
EUR 537.84

Agouti-Related Peptide (AgRP) (83-132) amide (Human)

003-53 100 μg
EUR 316.44

Agouti-Related Peptide (AgRP) (71-132), Form C amide (Human) - Antibody

H-003-55 50 μl
EUR 604.8

Gastrin Releasing Peptide (GRP) (14-27) (Human, Porcine)

027-16 500 μg
EUR 108

[Tyr0]-RFamide-Related Peptide 1 (RFRP-1) (Human)

048-43 200 μg
EUR 177.12

[Tyr0]-RFamide-Related Peptide 2 (RFRP-2) (Human)

048-45 200 μg
EUR 177.12

[Tyr0]-RFamide-Related Peptide 3 (RFRP-3) (Human)

048-47 200 μg
EUR 177.12

Prolactin-Releasing Peptide-31 (PrRP-31) (Human) - EIA Kit

EK-008-50 96 wells
EUR 603.72

Prolactin-Releasing Peptide-31 (PrRP-31) (Human) - RIA Kit

RK-008-50 125 tubes
EUR 932.04

Parathyroid Hormone-Like Peptide (PLP) (140-173) (Human)

056-17 200 μg
EUR 129.6

SHAAG Peptide / Chemokine (46-63) (Human) - Biotin Labeled

B-072-32 10 μg
EUR 267.84

Urotensin II Related Peptide (Human, Rat, Mouse) - Purified IgG Antibody

G-071-17 200 μg
EUR 604.8

Galanin-Like Peptide (GALP) (Human) - Rhodamine Labeled

FR-026-51 1 nmol
EUR 604.8

Galanin-Like Peptide (GALP) (Human) - I-125 Labeled

T-026-51 10 μCi
EUR 1145.88

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - I-125 Labeled Purified IgG

T-G-064-07 10 μCi
EUR 1145.88

Peptide YY (PYY) (3-36) (Human) - Magnetic Bead RIA Kit

MRK-059-02 125 tubes
EUR 1061.64

Prostate Specific Antigen (PSA) (243-261) / C-terminal PSA peptide (Human)

034-45 100 μg
EUR 199.8

Osteoblast Activating Peptide (OBAP) (Human) - Cy3 Labeled

FC3-055-52 1 nmol
EUR 756

Osteoblast Activating Peptide (OBAP) (Human) - Cy5 Labeled

FC5-055-52 1 nmol
EUR 756

Osteoblast Activating Peptide (OBAP) (Human) - FAM Labeled

FG-055-52 1 nmol
EUR 537.84

Galanin-Like Peptide (GALP) (Human) - Western Blot Kit

WBK-026-51 1 kit
EUR 822.96

prepro-Endothelin-1 (ET-1) Like Peptide (109-130) amide (Human)

023-11 100 μg
EUR 355.32

Peptide YY (PYY) (Human) - I-125 Labeled Purified IgG

T-G-059-01 10 μCi
EUR 1145.88

Gastrin Releasing Peptide (GRP) (Human) - I-125 Labeled

T-027-07 10 μCi
EUR 1145.88

Galanin-Like Peptide (GALP) (36-60) (Human) - FAM Labeled

FG-026-55A 1 nmol
EUR 604.8

SHAAG Peptide / Chemokine (46-63) (Human) - I-125 Labeled

T-072-32 10 μCi
EUR 1145.88

Peptide YY (PYY) (3-36) (Human) - Chemiluminescent EIA Kit

CEK-059-02 96 wells
EUR 660.96

SHAAG Peptide / Chemokine (46-63) (Human) - Rhodamine Labeled

FR-072-32 1 nmol
EUR 336.96

Prolactin-Releasing Peptide-31 (PrRP-31) (Human) - FAM Labeled

FG-008-50A 1 nmol
EUR 336.96

Prolactin-Releasing Peptide-20 (PrRP-20) (Human) - FAM Labeled

FG-008-51A 1 nmol
EUR 336.96

[Tyr0]-pro-Gastrin Releasing Peptide (GRP) (80-97) (Human)

027-36 100 μg
EUR 336.96

Prolactin-Releasing Peptide-31 (PrRP-31) (Human) - FITC Labeled

FG-008-50B 1 nmol
EUR 336.96

Peptide YY (PYY) (3-36) (Human) - Cy3 Labeled Purified IgG

FC3-G-059-02 100 μl
EUR 925.56

Peptide YY (PYY) (3-36) (Human) - Cy5 Labeled Purified IgG

FC5-G-059-02 100 μl
EUR 925.56

Peptide YY (PYY) (3-36) (Human) - FAM Labeled Purified IgG

FG-G-059-02A 100 μl
EUR 640.44

Agouti-Related Peptide (AgRP) (83-132) amide (Human) - Purified IgG Antibody

G-003-53 400 μg
EUR 604.8

TCAP-1 / Teneurin C-terminal Associated Peptide-1 (Human)

020-16 100 μg
EUR 317.52

TCAP-2 / Teneurin C-terminal Associated Peptide-2 (Human)

020-18 100 μg
EUR 317.52

TCAP-3 / Teneurin C-terminal Associated Peptide-3 (Human)

020-20 100 μg
EUR 317.52

TCAP-4 / Teneurin C-terminal Associated Peptide-4 (Human)

020-22 100 μg
EUR 317.52

Osteoblast Activating Peptide (OBAP) (Human) - Biotin Labeled

B-055-52 100 μg
EUR 469.8

Stresscopin Related Peptide (SRP) (Human) - Rhodamine Labeled

FR-019-27 1 nmol
EUR 537.84

Stresscopin Related Peptide (SRP) (Human) - I-125 Labeled

T-019-27 10 μCi
EUR 1145.88

ACTH (7-38) / Corticotropin Inhibiting Peptide (CIP) (Human)

001-12 200 μg
EUR 64.8

Gastrin Releasing Peptide-Gly (GRP-Gly) (18-27) (Human)

027-43 200 μg
EUR 160.92

GnRH Associated Peptide (GAP) / prepro-GnRH (37-92) (Human)

029-01 100 μg
EUR 405

Urotensin II Related Peptide (Human, Rat, Mouse) - RIA Kit

RK-071-17 125 tubes
EUR 1061.64

Peptide YY (PYY) (3-36) (Human) - Extraction-Free EIA Kit

EKE-059-02 96 wells
EUR 686.88

Peptide YY (PYY) (3-36) (Human) - EIA Kit, CE Mark Certified

EK-059-02CE 96 wells
EUR 645.84

Gastrin Releasing Peptide (GRP) (Human) - Fluorescent EIA Kit

FEK-027-07 96 wells
EUR 660.96

Peptide YY (PYY) (3-36) (Human) - Biotin Labeled Purified IgG

B-G-059-02 100 μl
EUR 63.72

Osteoblast Activating Peptide (OBAP) (Human) - I-125 Labeled

T-055-52 10 μCi
EUR 1145.88

Agouti-Related Peptide (AgRP) (54-82) (Human) - Biotin Labeled

B-003-52 20 μg
EUR 336.96

Galanin-Like Peptide (GALP) (36-60) (Human) - I-125 Labeled

T-026-55 10 μCi
EUR 1145.88

[Tyr0]-pro-Gastrin Releasing Peptide (GRP) (80-97) (Human) - Purified IgG Antibody

G-027-36 100 μg
EUR 370.44

prepro-RFamide Related Peptide (RFRP) (56-92) amide (Human)

048-54 100 μg
EUR 282.96

prepro-RFamide Related Peptide (RFRP) (115-131) amide (Human)

048-55 200 μg
EUR 214.92

The proper software have to be chosen for the correct job. In the world of COVID-19, FNABs could but once more show a invaluable and even important diagnostic software for symptomatic breast lesions.

Leave A Comment